CIK 0001817229
- Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811591163
- Phone
- +1 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,146 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 917 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 985 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 6,310 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 5,576 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,657 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,180 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,788 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 985 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,033 shares (to pay taxes)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 62,500 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 53,750 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 150,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 50,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 876 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 834 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 999 shares (to pay taxes)
Page 7 of 11 · 212 filings